** Carl Zeiss Meditec AG's AFXG.DE shares slip around 2% in early Frankfurt trade
** J.P.Morgan places the German optical systems maker on negative catalyst watch into Q2 results on May 14, sticking to its "underweight" rating
** The broker notes the stock rising 35% YTD, adding it struggles to justify the move as the firm sits in the bottom quartile for earnings growth and upper quartile for valuation
** It also highlights the firm's continued underperformance over the past two years and fears market share losses in China and the U.S.
** Carl Zeiss Meditec falls to the bottom of Germany's midcaps index .MDAXI
(Reporting by Tristan Veyet)
((Tristan.chabba@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。